These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

751 related articles for article (PubMed ID: 35674109)

  • 1. Cellular senescence and the tumour microenvironment.
    Takasugi M; Yoshida Y; Ohtani N
    Mol Oncol; 2022 Sep; 16(18):3333-3351. PubMed ID: 35674109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cellular senescence and SASP in tumour microenvironment.
    Takasugi M; Yoshida Y; Hara E; Ohtani N
    FEBS J; 2023 Mar; 290(5):1348-1361. PubMed ID: 35106956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of senescence on the tumour microenvironment and response to therapy.
    Reynolds LE; Maallin S; Haston S; Martinez-Barbera JP; Hodivala-Dilke KM; Pedrosa AR
    FEBS J; 2024 Jun; 291(11):2306-2319. PubMed ID: 37873605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Senescent cells and SASP in cancer microenvironment: New approaches in cancer therapy.
    Özdemir A; Şimay Demir YD; Yeşilyurt ZE; Ark M
    Adv Protein Chem Struct Biol; 2023; 133():115-158. PubMed ID: 36707199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing Functional Roles of the Senescence-Associated Secretory Phenotype (SASP).
    Malaquin N; Tu V; Rodier F
    Methods Mol Biol; 2019; 1896():45-55. PubMed ID: 30474839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles and mechanisms of senescence-associated secretory phenotype (SASP): can it be controlled by senolysis?
    Ohtani N
    Inflamm Regen; 2022 Apr; 42(1):11. PubMed ID: 35365245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies.
    D'Ambrosio M; Gil J
    Dev Cell; 2023 Jun; 58(12):1007-1021. PubMed ID: 37339603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Senescence and Immunotherapy: Redundant Immunomodulatory Pathways Promote Resistance.
    Oesterreich S; Aird KM
    Cancer Immunol Res; 2023 Apr; 11(4):401-404. PubMed ID: 36826438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer.
    Chambers CR; Ritchie S; Pereira BA; Timpson P
    Mol Oncol; 2021 Dec; 15(12):3242-3255. PubMed ID: 34137158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Emergence of Senescent Surface Biomarkers as Senotherapeutic Targets.
    Rossi M; Abdelmohsen K
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.
    Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
    FEBS J; 2023 Mar; 290(5):1362-1383. PubMed ID: 35015337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Senescence and the tumor-immune landscape: Implications for cancer immunotherapy.
    Chibaya L; Snyder J; Ruscetti M
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):827-845. PubMed ID: 35143990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic and scalable assessment of the senescence-associated secretory phenotype (SASP).
    Malaquin N; Rodier F
    Methods Cell Biol; 2024; 181():181-195. PubMed ID: 38302239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Senescence and senolysis in cancer: The latest findings.
    Imawari Y; Nakanishi M
    Cancer Sci; 2024 Jul; 115(7):2107-2116. PubMed ID: 38641866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting senescent cells to reshape the tumor microenvironment and improve anticancer efficacy.
    Jiang B; Zhang W; Zhang X; Sun Y
    Semin Cancer Biol; 2024 Jun; 101():58-73. PubMed ID: 38810814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aging microenvironment and antitumor immunity for geriatric oncology: the landscape and future implications.
    Zhao B; Wu B; Feng N; Zhang X; Zhang X; Wei Y; Zhang W
    J Hematol Oncol; 2023 Mar; 16(1):28. PubMed ID: 36945046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular senescence in the lung across the age spectrum.
    Parikh P; Wicher S; Khandalavala K; Pabelick CM; Britt RD; Prakash YS
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L826-L842. PubMed ID: 30785345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Senescent Cells in Cancer: Wanted or Unwanted Citizens.
    Niklander SE; Lambert DW; Hunter KD
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adamantinomatous craniopharyngioma as a model to understand paracrine and senescence-induced tumourigenesis.
    Gonzalez-Meljem JM; Martinez-Barbera JP
    Cell Mol Life Sci; 2021 May; 78(10):4521-4544. PubMed ID: 34019103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paracrine roles of cellular senescence in promoting tumourigenesis.
    Gonzalez-Meljem JM; Apps JR; Fraser HC; Martinez-Barbera JP
    Br J Cancer; 2018 May; 118(10):1283-1288. PubMed ID: 29670296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.